NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer HumesChief Accounting Officer2026-04-0813,538$28.37
$384.07kSell
Frank TortiPresident and Vant Chair2026-03-31160,035$27.70
$4.43MSell
Mayukh SukhatmePresident CIO2026-03-31187,512$27.70
$5.19MSell
Matthew GlineCEO2026-03-31304,684$27.70
$8.44MSell
Matthew GlineCEO2026-03-3053,826$26.41
$1.42MSell
Mayukh SukhatmePresident CIO2026-03-3029,809$26.41
$787.26kSell
Meghan FitzgeraldDirector2026-03-2670,000$8.80
$616.00kBuy
Meghan FitzgeraldDirector2026-03-2670,000$27.45
$1.92MSell
Jennifer HumesChief Accounting Officer2026-03-2014,526$27.70
$402.37kSell
Richard PulikCFO2026-03-201,546$27.70
$42.82kSell

1 of 20

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Qvt Financial LP16.11%115,268,226$3.28BInsider
Daniel Allen Gold15.14%108,333,636$3.09BInsider
Dexcel Pharma Technologies Ltd14.37%102,849,443$2.93BInsider
Keith S. Manchester10.22%73,167,574$2.08BInsider
Svf Investments Uk Ltd10.20%73,031,667$2.08BInsider
Sumitomo Chemical Co Ltd9.96%71,251,083$2.03BInsider
Fmr LLC9.19%65,779,464$1.87BInstitution
Morgan Stanley8.15%58,359,553$1.66BInstitution
Vivek Ramaswamy6.57%47,011,612$1.34BInsider
Vanguard Group Inc5.88%42,059,041$1.20BInstitution

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV43.12%56.88%Net SellingNet Selling
MRNA77.07%22.51%Net BuyingNet Selling
INCY77.98%22.02%Net SellingNet Selling
RVMD91.12%8.88%Net SellingNet Selling
GMAB100.00%0.00%

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 71.11% institutional shareholders, 93.79% Roivant Sciences insiders, and 0.00% retail investors. Qvt Financial LP is the largest individual Roivant Sciences shareholder, owning 115.27M shares representing 16.11% of the company. Qvt Financial LP's Roivant Sciences shares are currently valued at $3.25B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.